JOHNSON & JOHNSON is 279.5x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($574.10 B vs $2.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HRMY | JNJ |
|---|---|---|
| Market cap | $2.05 B | $574.10 B |
| US-listed rank | #2085 | #20 |
| Revenue (latest FY) | $868.45M | $94.19B |
| Net income (latest FY) | $158.69M | $26.80B |
| Net margin | 18.3% | 28.5% |
| P/E (trailing FY) | 12.9 | 21.4 |
| SEC filings | 434 | 984 |
JOHNSON & JOHNSON is 279.5x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($574.10 B vs $2.05 B).
In their latest fiscal years, Harmony Biosciences Holdings, Inc. reported $868.45M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Harmony Biosciences Holdings, Inc. and JOHNSON & JOHNSON, or browse the full rankings.